Dillard's (DDS) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The 2025 Annual Meeting is scheduled for May 17, 2025, with voting on director elections and auditor ratification.
Proxy materials are available online, and shareholders can vote by internet, phone, or mail.
Only shareholders of record as of March 20, 2025, are eligible to vote.
Voting matters and shareholder proposals
Shareholders will elect 15 directors: 5 by Class A and 10 by Class B stockholders.
Ratification of KPMG LLP as independent auditor for fiscal 2025 is on the agenda.
Shareholders may submit proposals for the 2026 meeting by December 5, 2025, for inclusion in the proxy.
Board of directors and corporate governance
The board consists of 15 directors, with Class A and B stockholders electing separate slates.
The company qualifies as a “controlled company” under NYSE rules, exempting it from certain independence requirements.
All Class A nominees and select Class B nominees are independent per NYSE standards.
The board has Audit, Compensation, and Executive Committees, with charters available online.
The CEO serves as board chairman, with the president assisting in daily operations.
Latest events from Dillard's
- Merger approved with no shareholder dilution, maintaining governance and proportional ownership.DDS
Proxy filing20 Mar 2026 - Stable annual results with strong cash position and record dividend, despite Q4 sales dip.DDS
Q4 202624 Feb 2026 - Retail sales and net income rose 3% in Q3, with strong cash flow and a $30 special dividend.DDS
Q3 20255 Dec 2025 - Director nominee Warren A. Stephens resigned; board seat to remain vacant until replacement elected.DDS
Proxy Filing2 Dec 2025 - Shareholders are voting on reincorporation to Texas, aiming for legal, tax, and governance benefits.DDS
Proxy Filing2 Dec 2025 - Proposal seeks shareholder approval to reincorporate from Delaware to Texas, preserving rights and reducing risk.DDS
Proxy Filing2 Dec 2025 - Director elections and auditor ratification headline the May 2025 annual meeting agenda.DDS
Proxy Filing2 Dec 2025 - Q2 2025 retail sales rose 1% with strong cash flow, stable EPS, and ongoing share repurchases.DDS
Q2 20255 Sep 2025 - Net income and sales fell, but gross margin stayed strong and a $25 dividend was declared.DDS
Q3 202413 Jun 2025